Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 60, 2005 - Issue 2
13
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

THE TREAT-TO-TARGET PARADIGM: A CROSS-SECTIONAL SURVEY OF CURRENT THERAPIES AND ACHIEVED METABOLIC CONTROL IN 800 TYPE 2 DIABETIC PATIENTS

&
Pages 79-85 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

D. Lienart, V. Preumont, O. Alexopoulou, J. Donckier, A. Colson, M.P. Hermans & M. Buysschaert. (2006) METABOLIC (GLYCAEMIC, LIPIDIC) AND BLOOD PRESSURE CONTROL IN 101 TYPE 2 DIABETIC PATIENTS ON FIRST ADMISSION TO DIABETES CENTRES. Acta Clinica Belgica 61:3, pages 127-133.
Read now

Articles from other publishers (3)

M. Buysschaert, V. Preumont, P.R. Oriot, I. Paris, M. Ponchon, D. Scarnière & P. Selvais. (2010) One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practice. Diabetes & Metabolism 36:5, pages 381-388.
Crossref
O Luminet, Ph de Timary, M Buysschaert & A Luts. (2006) The role of alexithymia factors in glucose control of persons with type 1 diabetes: a pilot study. Diabetes & Metabolism 32:5, pages 417-424.
Crossref
Eyal Leibovitz, Rafi Bitzur, Dror Harats & Dov Gavish. (2005) Beyond guidelines: achieving the optimum in LDL cholesterol control. Current Opinion in Lipidology 16:6, pages 635-639.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.